This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of benzodiazepines (BDZs) for panic disorder in adults, specifically: To determine the efficacy of BDZs in alleviating symptoms of panic disorder with or without agoraphobia in comparison to placebo; To review the acceptability of BDZs in panic disorder with or without agoraphobia in comparison with placebo; and To investigate the adverse effects of BDZs in panic disorder with or without agoraphobia, including the general prevalence of adverse effects, compared to placebo.
CITATION STYLE
Guaiana, G., Barbui, C., Chiodo, D., Cipriani, A., Davies, S. J. C., & Koesters, M. (2013). Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews, 2013(7). https://doi.org/10.1002/14651858.CD010677
Mendeley helps you to discover research relevant for your work.